Medicine and Dentistry
Heart Failure
92%
Acute Decompensated Heart Failure
80%
Diuretic Agent
27%
Kidney Function
26%
Combination Therapy
17%
Ejection Fraction
17%
Loop Diuretic Agent
15%
Congestive Heart Failure
14%
Titrimetry
14%
Acetazolamide
14%
Biological Marker
14%
Glomerular Filtration Rate
12%
Heart Failure with Reduced Ejection Fraction
11%
Brain Natriuretic Peptide
11%
Amino Terminal Sequence
10%
Urinary System
9%
Hazard Ratio
9%
Natriuresis
9%
Volume Overload
9%
Arm
9%
Adrenomedullin
8%
Pathophysiology
8%
ACE Inhibitor
7%
Mineralocorticoid Antagonist
7%
Drug Therapy
7%
Heart Left Ventricle Ejection Fraction
7%
Drug Megadose
6%
Creatinine
6%
Cardiovascular System
6%
Proenkephalin
6%
Quality of Life
5%
Placebo
5%
Keyphrases
Acute Heart Failure
61%
Heart Failure
31%
Patients with Heart Failure
23%
Heart Failure with Preserved Ejection Fraction (HFpEF)
17%
Up-titration
15%
Chronic Heart Failure
15%
Renal Function
15%
Clinical Outcomes
15%
Acetazolamide
14%
Decongestion
13%
High-intensity Care
13%
Acute Decompensated Heart Failure
13%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
11%
Heart Failure Trials
11%
Volume Overload
10%
Renal Function Improvement
9%
Diuretic Response
9%
All-cause Mortality
9%
Atrial Fibrillation
9%
Confidence Interval
9%
Failure Data
8%
Guideline-directed Medical Therapy
8%
Natriuresis
7%
Estimated Glomerular Filtration Rate
7%
Heart Failure Hospitalization
7%
Preserved Ejection Fraction
6%
Left Ventricular Ejection Fraction
6%
Congestion
6%
Loop Diuretics
6%
Heart Failure Patients
6%
Enkephalin
6%
Mineralocorticoid Receptor Antagonists
6%
Angiotensin Receptor Blockers
6%
Beta-blockers
5%
Diuretics
5%
Renal Disease
5%
Biology Study
5%
Tailored Treatment
5%
Randomized Clinical Trial
5%
Hospitalization
5%
Ejection Fraction
5%
Prognostic Value
5%
Usual Care
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
100%
Acute Heart Failure
84%
Diuretic Agent
28%
Loop Diuretic Agent
19%
Biological Marker
15%
Congestive Heart Failure
15%
Combination Therapy
14%
Acetazolamide
14%
All Cause Mortality
10%
Heart Failure with Reduced Ejection Fraction
10%
Brain Natriuretic Peptide
9%
Dipeptidyl Carboxypeptidase Inhibitor
9%
Adrenomedullin
8%
Placebo
8%
Creatinine
8%
Pathophysiology
7%
Hypochloremia
7%
Atrial Fibrillation
6%
Angiotensin Receptor Antagonist
6%
Mineralocorticoid Antagonist
6%
Inflammation
6%
Angiotensin
6%
Renin
6%
Proenkephalin
6%
Aldosterone
6%
Heart Failure with Preserved Ejection Fraction
5%